Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
QuintilesIMS
Daiichi Sankyo
Healthtrust
Mallinckrodt
Covington
US Department of Justice
US Army
Accenture

Generated: December 10, 2018

DrugPatentWatch Database Preview

Iroko Pharms Company Profile

« Back to Dashboard

What is the competitive landscape for IROKO PHARMS, and what generic alternatives to IROKO PHARMS drugs are available?

IROKO PHARMS has seven approved drugs.

There are thirteen US patents protecting IROKO PHARMS drugs.

There are eighty-nine patent family members on IROKO PHARMS drugs in twenty-four countries.

Summary for Iroko Pharms
International Patents:89
US Patents:13
Tradenames:5
Ingredients:3
NDAs:7

Drugs and US Patents for Iroko Pharms

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Iroko Pharms Llc VIVLODEX meloxicam CAPSULE;ORAL 207233-001 Oct 22, 2015 RX Yes No 9,649,318 ➤ Sign Up Y ➤ Sign Up
Iroko Pharms Llc VIVLODEX meloxicam CAPSULE;ORAL 207233-002 Oct 22, 2015 RX Yes Yes ➤ Sign Up ➤ Sign Up
Iroko Pharms Llc TIVORBEX indomethacin CAPSULE;ORAL 204768-001 Feb 24, 2014 RX Yes No 8,734,847 ➤ Sign Up Y ➤ Sign Up
Iroko Pharms Llc ZORVOLEX diclofenac CAPSULE;ORAL 204592-002 Oct 18, 2013 RX Yes Yes 8,999,387 ➤ Sign Up ➤ Sign Up
Iroko Pharms Llc ZORVOLEX diclofenac CAPSULE;ORAL 204592-002 Oct 18, 2013 RX Yes Yes 9,180,096 ➤ Sign Up Y ➤ Sign Up
Iroko Pharms Llc TIVORBEX indomethacin CAPSULE;ORAL 204768-001 Feb 24, 2014 RX Yes No 8,992,982 ➤ Sign Up Y ➤ Sign Up
Iroko Pharms Llc VIVLODEX meloxicam CAPSULE;ORAL 207233-002 Oct 22, 2015 RX Yes Yes 9,526,734 ➤ Sign Up Y ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Expired US Patents for Iroko Pharms

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Iroko Pharms INDOCIN SR indomethacin CAPSULE, EXTENDED RELEASE;ORAL 018185-001 Feb 23, 1982 4,173,626 ➤ Sign Up
Iroko Pharms INDOCIN indomethacin SUPPOSITORY;RECTAL 017814-001 Aug 13, 1984 3,849,549 ➤ Sign Up
Iroko Pharms INDOCIN indomethacin SUPPOSITORY;RECTAL 017814-001 Aug 13, 1984 3,644,630 ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Paragraph IV (Patent) Challenges for IROKO PHARMS drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Capsules 18 mg and 35 mg ➤ Subscribe 2014-06-06
➤ Subscribe Capsules 5 mg and 10 mg ➤ Subscribe 2017-01-09
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
Harvard Business School
Colorcon
Moodys
Argus Health
Accenture
Julphar
Merck
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.